Xylem Inc. (XYL) stock

XYLNYSEPumps & Pumping EquipmentFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 27, 2026Score 23/3029% below fair value

$92.40+1.64 (+1.81%)

Close on Oct 30, 2026Market cap $21.57BP/E 22.0Yield 1.73%

Earnings

Xylem's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 9, 2027

Q4 FY2026 · estimated, before the open

Revenue, Q3 FY2026

$2.20B

-4.3% on a year earlier

Adjusted EPS, Q3 FY2026

$1.44

$1.37 a year earlier

Latest guidance

Issued

Oct 27, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of Xylem's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Dec 31, 2026	Feb 9, 2027Expected	–	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Oct 27, 2026before the open	$2.20B	-4.3%	$1.25	$1.44	Release
Q2 FY2026ended Jun 30, 2026	Jul 28, 2026before the open	$2.30B	0.0%	$1.11	–	Release
Q1 FY2026ended Mar 31, 2026	Apr 28, 2026before the open	$2.10B	0.0%	$0.79	$1.12	Release
Q4 FY2025ended Dec 31, 2025	Feb 10, 2026before the open	$2.40B	–	$1.37	$1.42	Release
Q3 FY2025ended Sep 30, 2025	Oct 28, 2025before the open	$2.30B	+9.5%	$0.93	$1.37	Release
Q2 FY2025ended Jun 30, 2025	Jul 31, 2025before the open	$2.30B	+4.5%	$0.93	$1.26	Release
Q1 FY2025ended Mar 31, 2025	Apr 29, 2025before the open	$2.10B	+5.0%	$0.69	$1.03	Release
Q4 FY2024ended Dec 31, 2024	Jan 30, 2025after the close	–	–	–	–	Filing
Q3 FY2024ended Sep 30, 2024	Oct 31, 2024before the open	$2.10B	0.0%	$0.89	$1.11	Release
Q2 FY2024ended Jun 30, 2024	Jul 30, 2024before the open	$2.20B	+29.4%	$0.80	$1.09	Release
Q1 FY2024ended Mar 31, 2024	May 2, 2024before the open	$2.00B	+42.9%	$0.63	$0.90	Release
Q4 FY2023ended Dec 31, 2023	Feb 6, 2024before the open	$2.10B	+40.0%	$1.10	$0.99	Release
Q3 FY2023ended Sep 30, 2023	Oct 31, 2023before the open	$2.10B	+50.0%	$0.63	$0.99	Release
Q2 FY2023ended Jun 30, 2023	Aug 2, 2023before the open	$1.70B	+21.4%	$0.45	$0.98	Release
Q1 FY2023ended Mar 31, 2023	May 4, 2023before the open	$1.40B	+7.7%	$0.54	$0.72	Release
Q4 FY2022ended Dec 31, 2022	Feb 7, 2023before the open	$1.50B	+13.6%	$0.82	$0.92	Release
Q3 FY2022ended Sep 30, 2022	Nov 1, 2022before the open	$1.40B	+10.2%	$0.07	$0.79	Release
Q2 FY2022ended Jun 30, 2022	Aug 2, 2022before the open	$1.40B	–	$0.62	$0.66	Release
Q1 FY2022ended Mar 31, 2022	May 4, 2022before the open	$1.30B	–	$0.45	$0.47	Release
Q4 FY2021ended Dec 31, 2021	Feb 3, 2022before the open	$1.32B	–	$0.62	$0.63	Release
Q3 FY2021ended Sep 30, 2021	Nov 2, 2021before the open	$1.27B	–	$0.63	$0.63	Release
Q2 FY2021ended Jun 30, 2021	Aug 3, 2021before the open	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	May 4, 2021before the open	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Feb 4, 2021before the open	–	–	–	–	Release
Q3 FY2020ended Sep 30, 2020	Oct 29, 2020before the open	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Xylem's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
revenueGAAP	FY2026	$8.95B	–	New	Oct 27, 2026
revenueGAAP	FY2026	$9.20B	$9.10B – $9.20B	Raised	Jul 28, 2026
revenue	FY2026	$9.20B – $9.30B	–	New	Apr 28, 2026
revenue on a reported basis	FY2026	+2% – +3%	–	New	Apr 28, 2026
revenue on an organic basisnon-GAAP	FY2026	+2% – +3%	+2% – +4%	Lowered	Jul 28, 2026
adjusted EBITDA marginnon-GAAP	FY2026	23.2%	–	New	Oct 27, 2026
adjusted EBITDA marginnon-GAAP	FY2026	23.1% – 23.5%	22.9% – 23.3%	Raised	Jul 28, 2026
adjusted earnings per sharenon-GAAP	FY2026	$5.40 – $5.45	–	New	Oct 27, 2026
adjusted earnings per sharenon-GAAP	FY2026	$5.55 – $5.70	$5.35 – $5.60	Raised	Jul 28, 2026
free cash flow marginnon-GAAP	FY2026	10.2%	–	New	Oct 27, 2026
free cash flow marginnon-GAAP	FY2026	10.2% – 11%	10.2% – 11%	Reaffirmed	Jul 28, 2026

Guidance vs results

The last range Xylem gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	adjusted earnings per share	$5.03 – $5.08	$5.08Σ4Q	Within range
FY2025	Revenue	$9.00B	$9.10BΣ4Q	Above range

Guidance history

Every forecast Xylem put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Oct 27, 2026	adjusted EBITDA margin	FY2026	23.2%	New
Oct 27, 2026	adjusted earnings per share	FY2026	$5.40 – $5.45	New
Oct 27, 2026	free cash flow margin	FY2026	10.2%	New
Oct 27, 2026	revenue	FY2026	$8.95B	New
Jul 28, 2026	adjusted EBITDA margin	FY2026	23.1% – 23.5%	Raised
Jul 28, 2026	adjusted earnings per share	FY2026	$5.55 – $5.70	Raised
Jul 28, 2026	free cash flow margin	FY2026	10.2% – 11%	Reaffirmed
Jul 28, 2026	revenue	FY2026	$9.20B	Raised
Jul 28, 2026	revenue on an organic basis	FY2026	+2% – +3%	Lowered
Apr 28, 2026	adjusted EBITDA margin	FY2026	22.9% – 23.3%	Reaffirmed
Apr 28, 2026	adjusted earnings per share	FY2026	$5.35 – $5.60	Reaffirmed
Apr 28, 2026	free cash flow margin	FY2026	10.2% – 11%	Reaffirmed
Apr 28, 2026	revenue on a reported basis	FY2026	+2% – +3%	New
Apr 28, 2026	revenue on an organic basis	FY2026	+2% – +4%	Reaffirmed
Apr 28, 2026	revenue	FY2026	$9.20B – $9.30B	New
Feb 10, 2026	adjusted EBITDA margin	FY2026	22.9% – 23.3%	New
Feb 10, 2026	adjusted earnings per share	FY2026	$5.35 – $5.60	New
Feb 10, 2026	free cash flow margin	FY2026	10.2% – 11%	New
Feb 10, 2026	organic basis	FY2026	+2% – +4%	New
Feb 10, 2026	revenue	FY2026	$9.10B – $9.20B	New
Oct 28, 2025	adjusted EBITDA margin	FY2025	22% – 22.3%	Raised
Oct 28, 2025	adjusted earnings per share	FY2025	$5.03 – $5.08	Raised
Oct 28, 2025	free cash flow margin	FY2025	9% – 10%	Reaffirmed
Oct 28, 2025	revenue	FY2025	$9.00B	New
Jul 31, 2025	adjusted EBITDA margin	FY2025	21.3% – 21.8%	New
Jul 31, 2025	adjusted earnings per share	FY2025	$4.70 – $4.85	New
Jul 31, 2025	free cash flow margin	FY2025	9% – 10%	New
Jul 31, 2025	revenue growth reported	FY2025	+4% – +5%	New
Jul 31, 2025	organic revenue growth	FY2025	+4%	New
Jul 31, 2025	revenue	FY2025	$8.90B – $9.00B	New
Apr 29, 2025	adjusted earnings per share	FY2025	$4.50 – $4.70	New
Apr 29, 2025	adjusted EBITDA margin	FY2025	21.3% – 21.8%	New
Apr 29, 2025	free cash flow margin	FY2025	9% – 10%	Lowered
Apr 29, 2025	revenue on a reported basis	FY2025	+1% – +2%	New
Apr 29, 2025	revenue on an organic basis	FY2025	+3% – +4%	New
Oct 31, 2024	adjusted EBITDA margin	FY2024	20.5%	Reaffirmed
Oct 31, 2024	adjusted earnings per share	FY2024	$4.22 – $4.24	Narrowed
Oct 31, 2024	free cash flow conversion to net income	FY2024	120%	Reaffirmed
Oct 31, 2024	revenue	FY2024	$8.50B	New
Oct 31, 2024	revenue growth	FY2024	+15%	Raised
Oct 31, 2024	organic revenue growth	FY2024	+5%	Lowered
Jul 30, 2024	adjusted EBITDA margin	FY2024	20.5%	Raised
Jul 30, 2024	adjusted earnings per share	FY2024	$4.18 – $4.28	Raised
Jul 30, 2024	free cash flow conversion to net income	FY2024	120%	Raised
Jul 30, 2024	organic revenue growth	FY2024	+5% – +6%	Raised
Jul 30, 2024	revenue	FY2024	$8.55B	Raised
May 2, 2024	adjusted EBITDA margin	FY2024	20%	Raised
May 2, 2024	adjusted earnings per share	FY2024	$4.10 – $4.25	Raised
May 2, 2024	free cash flow conversion to net income	FY2024	115%	Reaffirmed
May 2, 2024	revenue on an organic basis	FY2024	+4% – +6%	Raised
May 2, 2024	revenue	FY2024	$8.50B	Raised
Feb 6, 2024	adjusted EBITDA margin	FY2024	19.4% – 19.9%	New
Feb 6, 2024	adjusted earnings per share	FY2024	$4.00 – $4.20	New
Feb 6, 2024	free cash flow conversion to net income	FY2024	115%	New
Feb 6, 2024	revenue	FY2024	+3% – +5%	New
Feb 6, 2024	revenue	FY2024	$8.40B – $8.50B	New
Oct 31, 2023	adjusted EBITDA margin	FY2023	19%	Raised
Oct 31, 2023	adjusted earnings per share	FY2023	$3.71 – $3.73	Raised
Oct 31, 2023	organic revenue growth	FY2023	+11%	Raised
Oct 31, 2023	revenue	FY2023	$7.30B	Raised
Aug 2, 2023	adjusted EBITDA margin	FY2023	18%	Raised
Aug 2, 2023	adjusted earnings per share	FY2023	$3.50 – $3.70	Raised
Aug 2, 2023	organic revenue growth	FY2023	+9% – +10%	Raised
Aug 2, 2023	revenue	FY2023	$7.20B	Raised
May 4, 2023	adjusted EBITDA margin	FY2023	17.5% – 18%	Reaffirmed
May 4, 2023	adjusted earnings per share	FY2023	$3.15 – $3.35	Raised
May 4, 2023	revenue growth	FY2023	+8% – +9%	New
May 4, 2023	organic revenue growth	FY2023	+8% – +9%	Raised
Feb 7, 2023	adjusted EBITDA margin	FY2023	17.5% – 18%	New
Feb 7, 2023	adjusted earnings per share	FY2023	$3.00 – $3.25	New
Feb 7, 2023	free cash flow conversion to net income	FY2023	100%	New
Feb 7, 2023	organic basis	FY2023	+4% – +6%	New
Feb 7, 2023	revenue	FY2023	$5.70B – $5.80B	New
Nov 1, 2022	adjusted EBITDA margin	FY2022	17%	Raised
Nov 1, 2022	adjusted earnings per share	FY2022	$2.65 – $2.75	Raised
Nov 1, 2022	revenue growth on a reported basis	FY2022	+4%	Narrowed
Nov 1, 2022	organic revenue growth	FY2022	+9% – +10%	Raised
Aug 2, 2022	adjusted EBITDA margin	FY2022	16.5% – 17%	Raised
Aug 2, 2022	adjusted earnings per share	FY2022	$2.50 – $2.70	Raised
Aug 2, 2022	revenue growth on a reported basis	FY2022	+3% – +5%	Raised
Aug 2, 2022	organic revenue growth	FY2022	+8% – +10%	Raised
May 4, 2022	adjusted EBITDA margin	FY2022	16% – 17%	Reaffirmed
May 4, 2022	adjusted earnings per share	FY2022	$2.40 – $2.70	Raised
May 4, 2022	revenue growth on a reported basis	FY2022	+1% – +3%	New
May 4, 2022	organic revenue growth	FY2022	+4% – +6%	Raised
Feb 3, 2022	adjusted EBITDA margin	FY2022	16% – 17%	New
Feb 3, 2022	adjusted earnings per share	FY2022	$2.35 – $2.70	New
Feb 3, 2022	revenue on an organic basis	FY2022	+3% – +5%	New
Feb 3, 2022	revenue	FY2022	$5.25B – $5.35B	New
Nov 2, 2021	adjusted earnings per share	FY2021	$2.40 – $2.50	New
Nov 2, 2021	free cash flow conversion	FY2021	80% – 90%	New
Nov 2, 2021	organic revenue growth	FY2021	+3% – +4%	New
Nov 2, 2021	revenue	FY2021	$5.10B – $5.20B	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.